当前位置:首页  冯新华  发表论文

To be continue.

 87.  Yu Y, Feng XH. TGF-β signaling in cell fate control and cancer.Curr Opin Cell Biol. 2019 Aug 1;61:56-63.

 86.  Yuan B, Liu J, Cao J, Yu Y, Zhang H, Wang F, Zhu Y, Xiao M, Liu S, Ye Y, Ma L, Xu D, Xu N, Li Y, Zhao B, Xu P, Jin J, Xu J, Chen X, Shen L, Lin X, Feng XH. PTPN3 acts as a tumor suppressor and boosts TGF-β signaling independent of its phosphatase activity. EMBO J. 2019 Jul 15;38(14):e99945.

 85.  Zhang Q, Xiao M, Gu S, Xu Y, Liu T, Li H, Yu Y, Qin L, Zhu Y, Chen F, Wang Y, Ding C, Wu H, Ji H, Chen Z, Zu Y, Malkoski S, Li Y, Liang T, Ji J, Qin J, Xu P, Zhao B, Shen L, Lin X, Feng XH. ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions. Nat Cell Biol. 2019 Feb;21(2):179-189.

 84.  Liu J, Zhao M, Yuan B, Gu S, Zheng M, Zou J, Jin J, Liu T, Feng XH. WDR74 functions as a novel coactivator in TGF-β signaling. J Genet Genomics. 2018 Dec 20;45(12):639-650.

 83.  Gu S, Feng XH. TGF-β signaling in cancer. Acta Biochim Biophys Sin (Shanghai). 2018 Oct 1;50(10):941-949.

 82.  Liu H, Dai X, Cao X, Yan H, Ji X, Zhang H, Shen S, Si Y, Zhang H, Chen J, Li L, Zhao JC, Yu J, Feng XH, Zhao B. PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression. EMBO Rep. 2018 Jun;19(6). pii: e45180.

 81.  Zhu C, Ji X, Zhang H, Zhou Q, Cao X, Tang M, Si Y, Yan H, Li L, Liang T, Feng XH, Zhao B. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. J Biol Chem. 2018 Jan 26;293(4):1178-1191.

 80.  Zhao N, Cao J, Xu L, Tang Q, Dobrolecki LE, Lv X, Talukdar M, Lu Y, Wang X, Hu DZ, Shi Q, Xiang Y, Wang Y, Liu X, Bu W, Jiang Y, Li M, Gong Y, Sun Z, Ying H, Yuan B, Lin X, Feng XH, Hartig SM, Li F, Shen H, Chen Y, Han L, Zeng Q, Patterson JB, Kaipparettu BA, Putluri N, Sicheri F, Rosen JM, Lewis MT, Chen X. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest. 2018 Apr 2;128(4):1283-1299.

 79.  Ma X, Chen X, Jin Y, Ge W, Wang W, Kong L, Ji J, Guo X, Huang J, Feng XH, Fu J, Zhu S. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells. Nat Commun. 2018 Apr 3;9(1):1303.

 78.  Zhao Y, Liu J, Chen F, Feng XH. C-terminal domain small phosphatase-like 2 promotes epithelial-to-mesenchymal transition via Snail dephosphorylation and stabilization. Open Biol. 2018 Apr;8(4). pii: 170274.

 77.  Sun S, Liu S, Zhang Z, Zeng W, Sun C, Tao T, Lin X, Feng XH. Phosphatase UBLCP1 controls proteasome assembly. Open Biol. 2017 May;7(5). pii: 170042.

 76.  Yu Y, Gu S, Li W, Sun C, Chen F, Xiao M, Wang L, Xu D, Li Y, Ding C, Xia Z, Li Y, Ye S, Xu P, Zhao B, Qin J, Chen YG, Lin X, Feng XH. Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling. Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10113-10118.

 75.  Si Y, Ji X, Cao X, Dai X, Xu L, Zhao H, Guo X, Yan H, Zhang H, Zhu C, Zhou Q, Tang M, Xia Z, Li L, Cong YS, Ye S, Liang T, Feng XH, Zhao B. Src inhibits the hippo tumor suppressor pathway through tyrosine phosphorylation of lats1. Cancer Res. 2017 Sep 15;77(18):4868-4880.

 74.  Liu T, Zhao M, Liu J, He Z, Zhang Y, You H, Huang J, Lin X, Feng XH. Tumor suppressor bromodomain-containing protein 7 cooperates with smads to promote transforming growth factor-β responses. Oncogene. 2017 Jan 19;36(3):362-372.

 73.  Xu P, Lin X, Feng XH. Posttranslational regulation of smads. Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12). pii: a022087.

 72.  Liu S, Long J, Yuan B, Zheng M, Xiao M, Xu J, Lin X, Feng XH. Sumo modification reverses inhibitory effects of smad nuclear interacting protein-1 in TGF-β responses. J Biol Chem. 2016 Nov 18;291(47):24418-24430.

 71.  Sun C, Wang G, Wrighton KH, Lin H, Songyang Z, Feng XH, Lin X. Regulation of p27Kip1 phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G. Am J Cancer Res. 2016 Oct 1;6(10):2207-2220.

 70.  Feng XH, Liang YY, Liang M, Zhai W, Lin X. Direct Interaction of c-Myc with Smad2 and Smad3 to Inhibit TGF-β-Mediated Induction of the CDK Inhibitor p15(Ink4B). Mol Cell. 2016 Apr 7;62(1):152.

 69.  Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, Shi Y, Chen YG, Meng A, Feng XH. PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling. Cell. 2016 Sep 8;166(6):1597.

 68.  Xiang W, Zhang Q, Lin X, Wu S, Zhou Y, Meng F, Fan Y, Shen T, Xiao M, Xia Z, Zou J, Feng XH, Xu P. PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1. Sci Adv. 2016 Jul 1;2(7):e1501889.

 67.  Liu T, Zhao M, Liu J, He Z, Zhang Y, You H, Huang J, Lin X, Feng XH. Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses. Oncogene. 2017 Jan 19;36(3):362-372.

 66.  Sun T, Fu J, Shen T, Lin X, Liao L, Feng XH, Xu J. The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation. J Biol Chem. 2016 May 27;291(22):11518-28.

 65.  Meng F, Zhou R, Wu S, Zhang Q, Jin Q, Zhou Y, Plouffe SW, Liu S, Song H, Xia Z, Zhao B, Ye S, Feng XH, Guan KL, Zou J, Xu P. Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation. Genes Dev. 2016 May 1;30(9):1086-100.

 64.  Wen L, Liang C, Chen E, Chen W, Liang F, Zhi X, Wei T, Xue F, Li G, Yang Q, Gong W, Feng X, Bai X, Liang T. Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent. Sci Rep. 2016 Mar 24;6:23269.

 63.  Guan L, Zhang L, Gong Z, Hou X, Xu Y, Feng XH, Wang H, You H. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1‐Nrf2 signaling. Hepatology. 2016 Jun;63(6):1914-27.

 62.  Gu S, Liu Y, Zhu B, Ding K, Yao TP, Chen F, Zhan L, Xu P, Ehrlich M, Liang T, Lin X, Feng XH. Loss of α-Tubulin Acetylation is Associated with TGF-β induced Epithelial-Mesenchymal Transition. J Biol Chem. 2016 Mar 4;291(10):5396-405.

 61.  Mu Y, Lou J, Srivastava M, Zhao B, Feng XH, Liu T, Chen J, Huang J. SLFN11 inhibits checkpoint maintenance and homologous recombination repair. EMBO Rep. 2016 Jan;17(1):94-109.

 60.  Yan X, Liao H, Cheng M, Shi X, Lin X, Feng XH, Chen YG. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling. J Biol Chem. 2016 Jan 1;291(1):382-92.

 59.  Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, Lin X, Feng XH. STAT3 selectively interacts with Smad3 to antagonize TGF-β. Oncogene. 2016 Aug 18;35(33):4388-98.

 58.  Dai X, Liu H, Shen S, Guo X, Yan H, Ji X, Li L, Huang J, Feng XH, Zhao B. YAP activates the Hippo pathway in a negative feedback loop. Cell Res. 2017 Aug;27(8):1073.

 57.  Zhou Y, Liang C, Xue F, Chen W, Zhi X, Feng XH, Bai X, Liang T. Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation. Oncotarget. 2015 Apr 30;6(12):10350-65.

 56.  Chen BW, Chen W, Liang H, Liu H, Liang C, Zhi X, Hu LQ, Yu XZ, Wei T, Ma T, Xue F, Zheng L, Zhao B, Feng XH, Bai XL, Liang TB. Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells. Mol Cancer Ther. 2015 Aug;14(8):1805-15.

 55.  Shen S, Guo X, Yan H, Lu Y, Ji X, Li L, Liang T, Zhou D, Feng XH, Zhao JC, Yu J, Gong XG, Zhang L, Zhao B. A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res. 2015 Sep;25(9):997-1012.

 54.  Chen F, Lin X, Xu P, Zhang Z, Chen Y, Wang C, Han J, Zhao B, Xiao M, Feng XH. Nuclear export of Smads by RanBP3L regulates BMP signaling and mesenchymal stem cell differentiation. Mol Cell Biol. 2015 May;35(10):1700-11.

 53.  Chen W, Wu J, Li L, Zhang Z, Ren J, Liang Y, Chen F, Yang C, Zhou Z, Su SS, Zheng X, Zhang Z, Zhong CQ, Wan H, Xiao M, Lin X, Feng XH, Han J. Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat Cell Biol. 2015 Apr;17(4):434-44.

 52.  Xue J, Lin X, Chiu WT, Chen YH, Yu G, Liu M, Feng XH, Sawaya R, Medema RH, Hung MC, Huang S. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis. J Clin Invest. 2014 Feb;124(2):564-79.

 51.  Lin YC, Lu LT, Chen HY, Duan X, Lin X, Feng XH, Tang MJ, Chen RH. SCP phosphatases suppress renal cell carcinoma by stabiling PML and inhibiting mTOR/HIF signaling. Cancer Res. 2014 Dec 1;74(23):6935-46.

 50.  Wang A, Pan D, Lee YH, Martinez GJ, Feng XH, Dong C. Cutting edge: Smad2 and Smad4 Regulate TGF-β-Mediated Il9 Gene Expression via EZH2 Displacement. J Immunol. 2013 Nov 15;191(10):4908-12.

 49.  Strand DW, Liang YY, Yang F, Barron DA, Ressler SJ, Schauer IG, Feng XH, Rowley DR. TGF-β induction of FGF-2 expression in stromal cells requires integrated smad3 and MAPK pathways. Am J Clin Exp Urol. 2014 Oct 2;2(3):239-48.

 48.  Zhao Y, Xiao M, Sun B, Zhang Z, Shen T, Duan X, Yu PB, Feng XH, Lin X. CTD Small Phosphatase Like 2 Modulates the Canonical BMP Signaling and Mesenchymal Differentiation via Smad Dephosphorylation. J Biol Chem. 2014 Sep 19;289(38):26441-50.

 47.  Chen J, Xia Y, Lin X, Feng XH, Wang Y. Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosis. Lab Invest. 2014 May;94(5):545-56.

 46.  Shen T, Sun C, Zhang Z, Xu N, Duan X, Feng XH, Lin X. Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H. Cell Res. 2014 Jun;24(6):727-41.

 45.  Feng Y, Wu H, Xu Y, Zhang Z, Liu T, Lin X, Feng XH. Zinc Finger Protein 451 is a novel Smad corepressor in Transforming Growth Factor-β signaling. J Biol Chem. 2014 Jan 24;289(4):2072-83.

 44.  Zuo W, Huang F, Chiang YJ, Li M, Du J, Ding Y, Zhang T, Lee HW, Jeong LS, Chen Y, Deng H, Feng XH, Luo S, Gao C, Chen YG. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. Mol Cell. 2013 Feb 7;49(3):499-510.

 43.  Qin H, Qu C, Yamaza T, Yang R, Lin X, Duan XY, Akiyama K, Liu Y, Zhang Q, Chen C, Chen Y, Qi HH, Feng XH, Le AD, Shi S. Ossifying fibroma tumor stem cells are maintained by epigenetic regulation of a TSP1/TGF-β/SMAD3 autocrine loop. Cell Stem Cell. 2013 Nov 7;13(5):577-89.

 42.  Zhou G, Wang H, Liu SH, Shahi KM, Lin X, Wu J, Feng XH, Qin J, Tan TH, Brunicardi FC. p38 MAP kinase interacts with and stablizws pancreatic and duodenal homeobox-1. Curr Mol Med. 2013 Mar;13(3):377-86.

 41.  Qin J, Wu SP, Creighton CJ, Dai F, Xie X, Cheng CM, Frolov A, Ayala G, Lin X, Feng XH, Ittmann MM, Tsai SJ, Tsai MJ, Tsai SY. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis. Nature. 2013 Jan 10;493(7431):236-40.

 40.  Zhou G, Liu SH, Shahi KM, Wang H, Duan X, Lin X, Feng XH, Li M, Fisher WE, Demayo FJ, Dawson D, Brunicardi FC. Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5. Mol Endocrinol. 2012 Jul;26(7):1225-34.

 39.  Jia S, Dai F, Wu D, Lin X, Xing C, Xue Y, Wang Y, Xiao M, Wu W, Feng XH, Meng A. Protein phosphatase 4 cooperates with Smads to promote BMP signaling in dorsoventral patterning of zebrafish embryos. Dev Cell. 2012 May 15;22(5):1065-78.

 38.  Lim JH, Jono H, Komatsu K, Woo CH, Lee J, Miyata M, Matsuno T, Xu X, Huang Y, Zhang W, Park SH, Kim YI, Choi YD, Shen H, Heo KS, Xu H, Bourne P, Koga T, Xu H, Yan C, Wang B, Chen LF, Feng XH, Li JD. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt. Nat Commun. 2012 Apr 10;3:771.

 37.  Dai F, Shen T, Li Z, Lin X, Feng XH. PPM1A dephosphorylates RanBP3 to enable efficient nuclear export of Smad2 and Smad3. EMBO Rep. 2011 Oct 28;12(11):1175-81.

 36.  Liu T, Feng XH. Regulation of TGF-β signaling by protein phosphatases. Biochem J. 2010 Sep 1;430(2):191-8.

 35.  Martinez GJ, Zhang Z, Reynolds JM, Tanaka S, Chung Y, Liu T, Robertson E, Lin X, Feng XH, Dong C. SMAD2 positively regulates the generation of Th17 cells. J Biol Chem. 2010 Sep 17;285(38):29039-43.

 34.  Inamoto S, Kwartler CS, Lafont AL, Liang YY, Fadulu VT, Duraisamy S, Willing M, Estrera A, Safi H, Hannibal MC, Carey J, Wiktorowicz J, Tan FK, Feng XH, Pannu H, Milewicz DM. TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. Cardiovasc Res. 2010 Dec 1;88(3):520-9.

 33.  Feng XH. The changing faces of cancer cells. Nat Rev Mol Cell Biol. 2010 Jul;11(7):466.

 32.  Dai F, Duan X, Liang YY, Lin X, Feng XH. Coupling of dephosphorylation and nuclear export of Smads inTGF-β signaling. Methods Mol Biol. 2010;647:125-37.

 31.  Martinez GJ, Zhang Z, Chung Y, Reynolds JM, Lin X, Jetten AM, Feng XH, Dong C. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J Biol Chem. 2009 Dec 18;284(51):35283-6.

 30.  Wrighton KH, Lin X, Yu PB, Feng XH. Transforming Growth Factor βCan Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors. J Biol Chem. 2009 Apr 10;284(15):9755-63.

 29.  Dai F, Lin X, Chang C, Feng XH. Nuclear export of Smad2 and Smad3 by RanBP3 facilitate termination of TGF-β signaling. Dev Cell. 2009 Mar;16(3):345-57.

 28.  Wrighton KH, Lin X, Feng XH. Phospho-control of TGF-β superfamily signaling. Cell Res. 2009 Jan;19(1):8-20.

 27.  Li C, Liang YY, Feng XH, Tsai SY, Tsai MJ, O'Malley BW. Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover. Mol Cell. 2008 Sep 26;31(6):835-49.

 26.  Wrighton KH, Lin X, Feng XH. Critical regulation of TGFβ signaling by Hsp90. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9244-9.

 25.  Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH, Jetten AM, Dong C. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008 Jul 18;29(1):44-56.

 24.  Wrighton KH, Dai F, Feng XH. A new kid on the TGF-β block: TAZ controls Smad nucleo-cytoplasmic shuttling. Dev Cell. 2008 Jul;15(1):8-10.

 23.  Wang D, Long J, Dai F, Liang M, Feng XH, Lin X. Bcl6 represses Smad signaling in TGF-β resistance. Cancer Res. 2008 Feb 1;68(3):783-9.

 22.  Dai F, Chang C, Lin X, Dai P, Mei L, Feng XH. Erbin inhibits TGF-β signaling through a novel Smad-interacting domain. Mol Cell Biol. 2007 Sep;27(17):6183-94.

 21.  Lim JH, Stirling B, Derry J, Koga T, Jono H, Woo CH, Xu H, Bourne P, Ha UH, Ishinaga H, Xu H, Andalibi A, Feng XH, Zhu H, Huang Y, Zhang W, Weng X, Yan C, Yin Z, Briles DE, Davis RJ, Flavell RA, Li JD. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity. 2007 Aug;27(2):349-60.

 20.  Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG. Smad7 antagonizes TGF-β signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol. 2007 Jun;27(12):4488-99.

 19.  Wrighton KH, Liang M, Bryan B, Luo K, Liu M, Feng XH, Lin X. TGF-β-independent regulation of myogenesis by SnoN SUMOylation. J Biol Chem. 2007 Mar 2;282(9):6517-24.

 18.  Ishinaga H, Jono H, Lim JH, Kweon SM, Xu H, Ha UH, Xu H, Koga T, Yan C, Feng XH, Chen LF, Li JD. TGF-βinduces p65 acetylation to enhance bacteria-induced NF-kB activation. EMBO J. 2007 Feb 21;26(4):1150-62.

 17.  Wang J, Li A, Wang Z, Feng X, Olson EN, Schwartz RJ. Myocardin Sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts. Mol Cell Biol. 2007 Jan;27(2):622-32.

 16.  Wrighton K, Willis D, Long J, Liu F, Lin X, Feng XH. Small carboxy-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance TGF-β signaling. J Biol Chem.2006; 281(50): 38365.75.

 15.  Duan X, Liang YY, Feng XH, Lin X. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem. 2006 Dec 1;281(48):36526-32.

 14.  Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, Shi Y, Chen YG, Meng A, Feng XH. PPM1A functions a Smad phosphatase to terminate TGF-β signaling. Cell. 2016 Apr 7;165(2):498.

 13.  Feng XH, Derynck R. Specificity and versatility of TGF-β signaling through Smads. Annu Rev Cell Dev Biol. 2005;21:659-93. Review.

 12.  Miura M, Chen XD, Allen MR, Bi Y, Gronthos S, Seo BM, Lakhani S, Flavell RA, Feng XH, Robey PG, Young M, Shi S. A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest. 2004 Dec;114(12):1704-13.

 11.  Wang J, Feng XH, Schwartz RJ. SUMO-1 modification activated GATA4 dependent cardiogenic gene activity. J Biol Chem. 2004 Nov 19;279(47):49091-8.

 10.  Liang M, Liang YY, Wrighton K, Ungermannova D, Wang XP, Brunicardi FC, Liu X, Feng XH, Lin X. Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol. 2004 Sep;24(17):7524-37.

 9.    Liang M, Melchior F, Feng XH. Regulation of Smad4 SUMOylation and TGF-β signaling by PIAS1. J Biol Chem.2004; 279(22): 22857.65.

 8.    Brown CO 3rd, Chi X, Garcia-Gras E, Shirai M, Feng XH, Schwartz RJ. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer. J Biol Chem. 2004 Mar 12;279(11):10659-69.

 7.    Lin X, Liang YY, Sun B, Liang M, Brunicardi FC, Feng XH. Smad6 recruits transcription corepressor CtBP to repress BMP-induced transcription. Mol Cell Biol.2003; 23(24): 9081-93.

 6.    Lin X, Liang M, Liang YY, Brunicardi FC, Feng XH. SUMO/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem.2003; 278(33): 31043-8.

 5.    Liang YY, Lin X, Liang M, Brunicardi FC, ten Dijke P, Chen Z, Choi KW, Feng XH. dSmurf selectively degrades decapentaplegic-activated MAD, and its overexpression disrupts imaginal disc development. J Biol Chem. 2003 Jul 18;278(29):26307-10.

 4.    Lin X, Sun B, Liang M, Liang YY, Gast A, Hildebrand J, Brunicardi FC, Melchior F, and Feng XH. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell. 2003; 11(5): 1389-96.

 3.    Lin X, Liang M, Liang YY, Brunicardi FC, Melchior F, and Feng XH.  Activation of TGF-βsignaling by SUMO modification of tumor suppressor Smad4/DPC4. J Biol Chem. 2003; 278(21):18714-9.

 2.    Feng XH, Liang YY, Liang M, Zhai W, and Lin X. Direct interaction of oncogenic c-Myc with tumor suppressors Smad2 and Smad3 to inhibit TGF-β-mediated induction of the     CDK inhibitor p15INK4B. Mol Cell. 2002; 9(1): 133-43.

 1.    Lin X, Liang M, Feng XH. Smurf2 as a ubiquitin E3 ligase for proteasome-dependent degradation of Smad2 in TGF-β signaling. J Biol Chem.2000; 275(47): 36818-22.